If the project succeeds, we’ll owe a debt to Brazos, a two-year-old Asian elephant who lives at the Fort Worth Zoo in Texas. He has just become the ninth animal to receive a test dose of a potentially groundbreaking vaccine designed to fend off one of the most serious threats facing his species.
The jab will hopefully protect him from elephant endotheliotropic herpesvirus (EEHV) — the biggest killer of baby Asian elephants living in captivity in Europe and North America, and a growing menace to endangered wild populations.
After promising initial results, a trial to test how well the vaccine works will be expanded to include about 25 more animals in the new year. If successful, the vaccine could be introduced on a much wider scale in three to five years.
To Learn More Click Here